Nuacht

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should ...
U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period should target newer strains of the JN.1 variant. COVID vaccine makers are ...
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...
The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...
An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...
Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.
Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...
Additionally, the Department of Health and Human Services unveiled the framework for the Most Favored Nation drug pricing ...
FDA COVID vaccine update is stirring major public attention as a new policy limits fall COVID-19 booster shots to seniors and ...